К содержанию
РецензированоEN2021

Neuroprotection in non-proliferative diabetic retinopathy

Bakhritdinova F.A. · Narzikulova K. I. · Urmanova F. M. · Mustafaeva M.K.

Научные статьи · 2021

Аннотация

Changes in the body that develop in patients with diabetes mellitus (DM) lead to disruption of all types of metabolism, angiopathy, polyneuropathy, as well as disruption of the function of almost all organs and tissues. Early detection of lesions and maintenance of normal functioning of the retinal and optic nerve tissue in the initial stages of DR is considered an extremely important stage of its secondary prevention which makes it advisable to include neuroprotective drugs in the complex of conservative therapy. One of the drugs of interest is Medotilin, a centrally acting cholinomimetic capable of preventing and correcting biochemical changes in nerve tissues and giving a pronounced nootropic effect.

Доказательный фрагмент

«Changes in the body that develop in patients with diabetes mellitus (DM) lead to disruption of all types of metabolism, angiopathy, polyneuropathy, as well as disruption of the function of almost all organs and tissues.»

Образец извлечения

Демо-превью

Changes in the body that develop in patients with diabetes mellitus (DM) lead to disruption of all types of metabolism, angiopathy, polyneuropathy, as well as disruption of the function of almost all organs and tissues. Полный текст публикации CiteX не хранит — доступ к первоисточнику открывается по DOI согласно лицензии издателя и выбранному плану.

DOI не указан
Цитирований
0
Просмотров
0
Тип
Журнал
Страна
Узбекистан
Спросить CiteX об этой работе

Смежные источники